Zymeworks (ZYME) Misses Q4 EPS, Revenue Beats

Zymeworks (NASDAQ: ZYME) reported Q4 EPS of $4.71, $0.13 worse than the analyst estimate of $4.84. Revenue for the quarter came in at $402.49 million versus the consensus estimate of $371.3 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• Sempra names new CFO and SoCalGas CEO amid infrastructure deal
• Zymeworks (ZYME) PT Raised to $31 at Truist Securities